Description
Health Canada reviewed the potential risk of liver injury with Pradaxa after receiving reports of severe liver injury from the manufacturer. The manufacturer was asked to provide all available data on Pradaxa and the risk of liver injury.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Summary Safety Review - PRADAXA (dabigatran etexilate) - Assessing the potential risk of liver injury | HTML | Open resource | |
| Summary Safety Review - PRADAXA (dabigatran etexilate) - Assessing the potential risk of liver injury | HTML | Open resource |